Plant based formulation for the prevention and management of metabolic syndrome and cardiovascular disease mortality risk
US9381224B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 25, 2014 |
| Grant date | Jul 5, 2016 |
| Priority date | — |
| Expiry date | Jan 3, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/37
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a plant based formulation for the prevention and management of Metabolic Syndrome and Cardiovascular disease mortality risk comprising an effective amount of a hydro-alcoholic extract of Salacia parviflora, Tribulus terrestris and Dioscorea glabra.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.